The Biden administration and the U.S. Food and Drug Administration (FDA) took heat online this week after the FDA announced the removal of emergency use authorization for two monoclonal antibodies, which effectively shut down treatment sites statewide in Florida.
The FDA said in its statement that it is removing the authorization because the treatments “are highly unlikely to be active against the omicron variant.”
“Florida disagrees with the decision that blocks access to any available treatments in the absence of clinical evidence,” the Florida Health Department blasted in a press release. “To date, such evidence has not been provided by the United States Food and Drug Administration (FDA).”
Florida Governor Ron DeSantis (R) similarly blasted the Biden administration over the FDA move.
“Without a shred of clinical data to support its decision, the Biden Administration has revoked the emergency use authorization for lifesaving monoclonal antibody treatments,” the governor posted to Twitter.
“Floridians have benefited from the state’s treatment sites and their access to treatment shouldn’t be denied based on the whims of a floundering president,” DeSantis wrote.